Cite
P-044: Comparison of 10 Color Flowcytometry and PET/CT for prognosticating MM post-transplant: results from IMPOSE-BORTECON trial.
MLA
Yanamandra, Uday, et al. “P-044: Comparison of 10 Color Flowcytometry and PET/CT for Prognosticating MM Post-Transplant: Results from IMPOSE-BORTECON Trial.” Clinical Lymphoma, Myeloma & Leukemia, vol. 21, Oct. 2021, p. S62. EBSCOhost, https://doi.org/10.1016/S2152-2650(21)02178-9.
APA
Yanamandra, U., Ahuja, A., Kapoor, R., Pramanik, S., Das, S., Khurana, H., Mishra, K., Kumar, R., Sharma, S., Chatterjee, T., & Nair, V. (2021). P-044: Comparison of 10 Color Flowcytometry and PET/CT for prognosticating MM post-transplant: results from IMPOSE-BORTECON trial. Clinical Lymphoma, Myeloma & Leukemia, 21, S62. https://doi.org/10.1016/S2152-2650(21)02178-9
Chicago
Yanamandra, Uday, Ankur Ahuja, Rajan Kapoor, Suman Pramanik, Satyaranjan Das, Harshit Khurana, Kundan Mishra, et al. 2021. “P-044: Comparison of 10 Color Flowcytometry and PET/CT for Prognosticating MM Post-Transplant: Results from IMPOSE-BORTECON Trial.” Clinical Lymphoma, Myeloma & Leukemia 21 (October): S62. doi:10.1016/S2152-2650(21)02178-9.